Cholesterol Synthesis & Lipoprotein Transport Flashcards

(47 cards)

1
Q

Cholesterol

A
  • waxy steroid metabolite found in cell membranes and transported in blood by lipoproteins
  • important component of bile acids, steroid hormones, and vitamin D
  • part of cell membranes
  • principal sterol synthesized by animals
  • synthesis in 4 stages
  • initially isolated from gall stones in 1978
  • 27C, greasy insoluble solid
  • 4 fused ring structure (A, B, C, D)
    • 3-OH is hydrophilic
    • rest is hydrophobic and planar
    • unique 5-6 unsaturated bond
    • unique YVY tail at C17
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chole

A

Greek for bile

steros = solid

-ol = alcohol

origin of the name cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

membrane permeability

A

cholesterol is a requirement for proper membrane permeability and fluidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Steroid hormones

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HMG-CoA

A

hydroxymethylglutaryl-CoA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

isoprene

A
  • product of step 2 in cholesterol synthesis (from mavolonate)
  • rubber and latex are compounds of isoprene
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

squalene

A
  • product of stage 3 cholesterol synthesis
  • 30C
  • precursor to:
    • cholesterol in animals
    • stigmasterol in plants
    • ergosterol in fungi (inh by Ketoconazole, an antifungal drug)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HMG-CoA reductase

A
  • hyperactivity can lead to ++cholesterol production and arteriosclerosis due to elevated blood LDL
  • common clinical target for maintenance of cholesterol levels
  • +fbk inhibits it by +breakdown of the reductase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

familial hypercholesterolaemia

A
  • pathology of cholesterol overload
  • Nobel Prize: Goldstein & Brown, 1985
  • inherited dominant disorder of mutations in the LDL receptor gene
  • get atherosclerosis before pubery, MI mid-20s
  • 1/500 heterozygous, 1/1mil in severe homozygous form
    • homozygous form develops xanthomas - waxy plaques under skin on elbows, knees, buttocks; deosits on tendons and around cornea
  • suspected in anyone with cholesterol levels > 15mM with a family history of early MI
  • confirmed with analysis of LDL receptor gene
  • treated with HMG-CoA reductase inhibitors - statins e.g. Lipitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

chylomicrons

A
  • low proportion of free cholesterol and cholesteryl esters to TGs
  • transporting TGs from fats in intestine
  • deposit fat in mammary, muscle, and adipose tissues
  • ApoC-II is recognized by receptors in these tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

VLDL

A
  • very-low density lipoprotien
  • formed in liver
  • low free cholesterol and cholesteryl ester content relative to TGs (less than chylomicrons, though)
  • primarily delivers TG to tissues (mammary, muscle, adipose)
    • remnants (IDL) either go back to liver or lose ApoC-II and retain ApoB-100 –> LDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

LDL

A
  • highest ratio of cholesteryl esters to TGs and free cholesterol
  • tf donates TGs to tissues (mammary, skeletal, adipose)
  • ApoB-100 is recognized by LDL receptors on extrahepatic tissue or the liver
  • LDL formed from VLDL in plasma
    • some deposits TG into extrahepatic tissues
    • some goes back to liver for repackaging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HDL

A
  • structure solved in 2006-7
  • low ratio of free cholesterol (~more than chylo), lowest ratio of TGs
  • higher ratio of cholesteryl esters than chylo and LDL
  • greatest protein and phospholipid content
  • tf scavenges TGs from tissues
  • formed when ApoA-I activates LCAT in tissues to take up cholesteryl esters
  • acts on macrophages to stop them becoming foam cells (important in atherosclerosis)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

lipoprotein

A
  • contains lipids and proteins
    • monophospholipid layer (containing unesterified cholesterol)
    • hydrophobic lipid core (containing cholesteryl esters and TGs)
  • carry cholesterol in the blood
  • includes:
    • chylomycrons
    • VLDL
    • LDL
    • HDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Cholesterol made in the liver is

A

Stored as cholesteryl esters for export in VLDL

  • removal of polar 3-OH by ACAT (acyl-CoA-cholesterol acyl transferase)

Bile acids (polar detergent derivatives w/intact 3-OH)

  • stored in gall bladder to emulsify fat

Membranes (8%)

  • optimized for 37 deg C
  • makes membrane less fluid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is Acetyl-CoA transported across the mitochondrial membrane into the cytosol for cholesterol synthesis?

A
  • ACoA combines w/oxaloacetate –> citrate (part of Krebs)
  • citrate via transporter –> cytosol
  • undergoes reverse reaction –> ACoA + oxaloacetate
  • NADPH generated drives the synthetic pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the clinical target of cholesterol synthesis for regulation of its production?

A

HMG-CoA reductase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is stage 1 of cholesterol synthesis from A-CoA?

A

acetate –> mevaolonate

  • losing C=O
  • transfer of 2C from CoA to another A-CoA by thiolase
  • addition of another 2C from A-CoA by HMG-CoA synthase to produce HMG-CoA
  • HMG-CoA reductase then converts it to Mevalonate
    • driven by 2 NADPH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is stage 2 of cholesterol synthesis from A-CoA?

A

Mevalonate –> activated isoprene (5C)

  • consumes 3 ATP
  • loss of CO2 + phosphate group
  • rubber and latex are compounds of isoprene
20
Q

What is stage 3 of cholesterol synthesis from A-CoA?

A

isoprene (5C) to squalene (30C)

21
Q

What is stage 4 of cholesterol synthesis from A-CoA?

A

squalene –> cholesterol in endoplasmic reticulum

  • removal of 3C
  • final step catalyzed by 7-dehydrocholesterol reductase (DHCR 7)
    • defect causes Smith-Lemli-Opitz syndrome
  • in plants, get stigmasterol
  • in fungi, get ergosterol
    • antifungal ketoconazole inhibits this conversion
22
Q

ApoA-I

A
  • in HDL
  • activates LCAT (lecithin cholesterol acly transferase), makes esters
23
Q

ApoC-II

A
  • on chylomicrons, VLDL, HDL
  • activates lipoprotein lipase (breaks down TG for use in cells)
24
Q

How is fat metabolised into the different types of cholestrol?

A
  • FFAs absorbed in intestine –> TGs
  • TGs packaged into chylomicrons –> bloodstream via lymphatics
    • blood plamsa turns turbid after a meal
  • mammary, muscle, & adipose tissue have ApoC-II receptors (chylo, LDL, HDL)
    • take up TG, leaving chylo remnants –> liver
  • liver packages VLDL
    • mammary, muscle, adipose tissue w/ApoC-II
    • take up TG, leave VLDL remnants (IDL)
    • OR loses ApoC and retains ApoB-100 –> LDL
    • LDL donates TG to extrahepatic tissues or returns to liver
  • ApoA-I (liver and intestine, HDL precursor) scavenges cholesterol from extrahepatic tissues –> HDL, back to liver
25
LCAT
lecithin-cholesterol acyl transferase * in plasma * helps HDL scavenge cholesterol * ApoA-I protein around HDL activates LCAT by binding to the tissue membranes * accepts cholesterol (cholesteryl esters) * HDL is then composed of cholesterol and phospholipid (lecithin) from the membrane
26
ACAT
acyl-CoA-cholesterol acyl transferase * in liver cells * helps VLDL formation: * forms cholesteryl esters from pure cholesterol and fatty acyl CoA
27
What is considered a high blood cholesterol level?
plasma cholesterol \> 5.5 mmol/L
28
What causes thrombus formation in atherosclerosis?
Ruptured plaques display tissue factor on foam cell membranes this activates the extrinsic coagulation pathway (exacerbated by decreased endothelial production of NO and prostacyclin/PGI2 which are anticoagulants and vasodilators)
29
Describe how LDL is taken up by liver cells
receptor mediated endocytosis * nucleus produces 2 types of LDL receptors (one defective gene = only one functional receptor/half the amount on membrane e.g. FH) * LDL R recognizes ApoB-100, promoting endocytosis * endosome forms * LDL receptor detaches --\> membrane * endosome fuses with lysosome * LDL degrared to AA, FA, cholesteryl esters * cholesteryl ester droplet -fbk HMG-CoA reductase to inhibit cellular synthesis of cholesterol * in FH cells don't take up the LDL * tf get high circulating LDL * + cellular cholesterol production bc HMG-CoA reductase is not being inhibited
30
Statins
* competitive inhibitors of HMG-CoA reductase * stop conversion of HMG-CoA to mevalonate --\> -cholesterol * e.g. Compactin, Simvastatin (Zocor), Pravastatin (Pravachol), Lovastatin (Mevacor), Rosuvastatin (Crestor), Atrovastatin (Lipitor) * generally safe, but inhibit production of Ubiquinone, Q10 (in ETC) by inhibiting production of the precursor isoprene * tf can cause skeletal and cardiac muscle complications that can lead to heart faulure (myopathy, myotoxicity) * alleviated myotoxicity with Q10 supplements * taken by 1/3 Australians over 50 * costs +$1b/year * concerns: dispose to type II diabetes, dimentia
31
What is the mechanism of ezetimibe in treatment of hypercholesterolaemia?
* inhibits cholesterol absorption * binds to a sterol transporter in the intestine * does not affect absorption of bile acids or fat solubel vitamins * lowers LDL
32
What are the possible side effects of ezetimibe?
* diarrhea * headache * tiredness * allergic reactions * severe joint or stomach pain
33
How can ezetimibe be prescribed to lower cholesterol?
* effective alone in statin-intolerant patients * can be used in combination with all other lipid-lowering agents * overcomes the ceiling effect of lowering LDL with statins * can reduce dose of statins to minimize adverse effects
34
How can nicitonic acid/niacin reduce choleseterol?
* nicotinic acid = niacin = vitamin B3 * decrease VLDL from liver * reduce plasma LDL and TG * increases HDL * lowers atherogenic lipoprotein A from LDL found in placques that inhibits thrombosis
35
What are the common adverse effects of niacin?
* vasodilation * flushing (tolerance develops) * hypotension * nausea, vomiting (tolerance develops)
36
What are the rare adverse effects of niacin?
* itching * glucose intolerance * uric acid retention * increase hepatic impairment
37
What is the mechanism of fibrates in hypertriglycerideaemia treatment?
e.g. gemfibrozil, fenofibrate * agonists at nuclear receptors to regulate gene expression * peroxisome proliferator activated receptor alpha * increased synthesis of lipoprotein lipase (LPL) * breaks down TG to FFA at tissue tf -plasma TGs * moderately increases HDL * variable effects on LDL (may increase tf not 1st line drug)
38
What are the indications for fibrates?
* adjunct therapy to dietary changes for high TGs * mixed hyperlipidaemia * 2nd line therapy for hypercholesterolaemia
39
What are the precautions of using fibrates?
* mild elevation of serum aminotransferase * marker of liver toxicity * monitor every 3mo
40
What are the common adverse effects of fibrates?
* nausea * dry mouth * headache * rash
41
What are the rare adverse effects of fibrates?
* arrhythmias * gallstones * photosensitivity * impotence * depression
42
What are the Omega-3 fatty acids?
eicoapentanoic acid (EPA) docosahexanoic acid (DHA) in oily fish
43
What is the benefit of Omega-3 fatty acids?
Reduce triglycerides and LDL
44
What are the possible side effects of fish oils?
* aftertaste, fishy burp * diarrhea, abdominal discomfort * blood thinning effect (tf affects coagulation)
45
What is the polytherapy for severe hypertriglyceridaemia?
* low fat diet * fibrates * fish oils * statins * niacin * orlistat (inhibits fat absorption from gut)
46
Orlistat
* used in obesity * inhibits fat absorption in the gut by inhibiting lipase activity * causes explosive diarrhea after a fatty meal * can lead to behavioural modifications
47